医学
心脏病学
内科学
径向应力
经皮
斑点追踪超声心动图
心室流出道
烧蚀
射频消融术
梗阻性心肌病
拉伤
心肌病
肥厚性心肌病
酒精间隔消融
射血分数
心力衰竭
有限元法
物理
热力学
作者
Jing Li,Juan Zhang,Yu Shi,Horst Sievert,Cynthia C. Taub,Stefan Bertog,Shengjun Ta,Changhui Lei,Ethan Senser,Jing Wang,Rui Hu,Junzhe Huang,Fangqi Ruan,Yupeng Han,Xiaojuan Li,Bo Wang,Xueli Zhao,Jiao Liu,David H. Hsi,Liwen Liu
出处
期刊:Heart
[BMJ]
日期:2022-10-21
卷期号:109 (4): 289-296
被引量:11
标识
DOI:10.1136/heartjnl-2022-321597
摘要
Objective Echocardiography-guided Percutaneous IntraMyocardial Septal Radiofrequency Ablation (PIMSRA, Liwen procedure) is a novel treatment option for hypertrophic obstructive cardiomyopathy (HOCM). The impact of PIMSRA on myocardial mechanics is unknown. Methods Between October 2016 and June 2019, PIMSRA and 3-dimentional speckle tracking echocardiography were performed in 82 patients. Echocardiographic imaging, qualitative and quantitative clinical assessment were completed at baseline, immediately postprocedure and 1-year follow-up. Results There was a significant reduction in the peak left ventricular outflow tract (LVOT) gradients immediately following PIMSRA and at 1-year follow-up (resting gradients: from 83.50 (61.25) to 23.00 (41.75) mm Hg, p<0.001 and 13.50 (21.75) mm Hg, p<0.001, respectively; stress-induced gradients: from 118.25 (96.02) to 47.00 (74.50) mm Hg (1 year), p<0.001). There was an improvement in exercise time on stress echocardiography (p<0.001) and distance by 6 min walk test (p=0.034). Immediately after PIMSRA, there was a significant reduction in radial and circumferential strain in the ablated segments (p<0.001), with no change of longitudinal strain. At 1-year follow-up, the radial and circumferential strain recovered in the ablated segments. Meanwhile, left ventricular regional and global longitudinal strain had improved significantly (p<0.05). Conclusions PIMSRA is an effective treatment for symptomatic HOCM that resulted in a sustained improvement in exercise capacity, a persistent decrease in LVOT gradient, and a measurable increase in myocardial contractile function. Trial registration number NCT04777188 .
科研通智能强力驱动
Strongly Powered by AbleSci AI